Press release
Immuno-oncology Market Outlook 2024 to 2034: Growth Insights with Bristol Myers Squibb, F. Hoffmann-La Roche AG, Merck & Co., Novartis, AstraZeneca, Pfizer, GSK, Others
Immuno-Oncology Market
By the end of 2034, the market size is expected to reach a remarkable US$ 111.64 billion, driven by revolutionary breakthroughs in cancer treatment, expanding therapeutic applications, and increased adoption of immune-based therapies.
Browse full report - https://www.factmr.com/report/immuno-oncology-market
Unlocking the Potential of Immuno-oncology
Immuno-oncology represents a paradigm shift in cancer treatment by harnessing the body's own immune system to detect and destroy malignant cells. Unlike traditional cancer therapies such as chemotherapy and radiation, immuno-oncology offers long-term survival benefits, fewer side effects, and higher specificity. This has positioned it at the forefront of oncology research and therapeutic development, attracting investments from pharmaceutical giants and biotech innovators alike.
Recent Developments Driving Market Momentum
The immuno-oncology market has seen an acceleration in innovation in recent years. Notable developments include:
• FDA and EMA approvals of new immune checkpoint inhibitors (ICIs) for multiple cancer types.
• Combination therapies that pair ICIs with chemotherapy or targeted agents showing improved response rates in clinical trials.
• Advancements in personalized cancer vaccines, which tailor immunotherapy based on individual tumor biomarkers.
• A rise in strategic collaborations, such as Merck's recent partnerships with biotech firms for T-cell receptor therapies and AstraZeneca's investment in next-generation bispecific antibodies.
Moreover, the increasing integration of artificial intelligence (AI) and genomics in drug discovery is enhancing the development pipeline, allowing for faster identification of potential immunotherapy targets.
Key Players and Competitive Landscape
The competitive landscape of the immuno-oncology market is marked by intense R&D activities, robust product pipelines, and aggressive strategic alliances. Some of the most influential players shaping the future of this space include:
• Bristol Myers Squibb (BMS): BMS continues to lead the market with its flagship checkpoint inhibitors, Opdivo (nivolumab) and Yervoy (ipilimumab), which are approved for multiple indications including melanoma, lung, and renal cancers.
• F. Hoffmann-La Roche AG: Roche is focusing heavily on combination therapies and continues to expand its pipeline with drugs like Tecentriq (atezolizumab), which has gained approvals for bladder, lung, and breast cancers.
• Merck & Co.: Known for Keytruda (pembrolizumab), Merck dominates the ICI segment with a strong clinical development program targeting over 30 tumor types. Keytruda remains one of the top-selling oncology drugs globally.
• AstraZeneca: With its checkpoint inhibitor Imfinzi (durvalumab), AstraZeneca is focusing on non-small cell lung cancer and expanding into other indications through combination regimens.
• Novartis and GSK: These players are increasingly investing in CAR-T cell therapies, which represent a promising frontier within immuno-oncology.
• Pfizer: Through mergers and acquisitions, including its partnership with BioNTech, Pfizer is building a strong position in the cancer immunotherapy domain.
The growing competition is also evident from the rise of biotech startups, which are developing niche technologies like oncolytic viruses, cancer neoantigen vaccines, and immune system modulators, often collaborating with larger pharma firms to fast-track commercialization.
Get Your Copy Today - https://www.factmr.com/checkout/9418
Regional Outlook
• North America holds the largest market share, driven by favorable reimbursement policies, robust clinical research infrastructure, and high awareness of novel cancer therapies.
• Europe is a close second, with increasing adoption of combination immunotherapies and strong regulatory support.
• Asia Pacific is expected to grow at the fastest rate due to rising cancer prevalence, improving healthcare access, and growing investments by domestic biotech firms in countries like China, Japan, and India.
Want a Sample Before Buying? Download Free Sample
https://www.factmr.com/connectus/sample?flag=S&rep_id=9418
Final Outlook
The immuno-oncology market is entering a golden era of innovation and growth. As therapies become more personalized and combination treatments more effective, the market will continue to see rapid evolution, backed by cutting-edge research and strategic partnerships across the pharmaceutical ecosystem.
For stakeholders-from biotech innovators to healthcare investors and policy makers-this presents a timely opportunity to tap into one of the most transformative spaces in the life sciences sector.
Market Segmentation:
By Therapy Type
• Immune Checkpoint Inhibitors
• Immune System Modulators
• Cancer Vaccines
• Oncolytic Virus
• Others
By Therapeutic Area:
• Melanoma
• Lung Cancer
• Blood Cancers
• Renal Cell Carcinoma
• Prostate Cancer
• Bladder Cancer
• Other Cancers
By End User:
• Hospitals
• Clinics
• Ambulatory Surgical Centers
By Region:
• North America
• Europe
• Latin America
• East Asia
• South Asia & Oceania
• The Middle East & Africa
Explore More Related Studies Published by Fact.MR Research
Fungal Antigens Market
https://www.factmr.com/report/1773/fungal-antigens-market
Disposable Ophthalmic Surgical Products Market https://www.factmr.com/report/1771/disposable-ophthalmic-surgical-products-market
Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com
About Fact.MR
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Immuno-oncology Market Outlook 2024 to 2034: Growth Insights with Bristol Myers Squibb, F. Hoffmann-La Roche AG, Merck & Co., Novartis, AstraZeneca, Pfizer, GSK, Others here
News-ID: 4133132 • Views: …
More Releases from Factmr
Vascular Grafts Market Valued at USD 4.23 Billion in 2025 | Medtronic PLC, Cook …
The global vascular grafts market is estimated at US$ 3.73 billion in 2023 and is predicted to climb to a value of US$ 7.04 billion by the end of 2033. As per this detailed Fact.MR research analysis, worldwide demand for vascular grafts is forecasted to rise at a healthy 6.5% CAGR over the next ten years.This robust growth is driven by the surging prevalence of cardiovascular disorders, chronic renal diseases,…
Neurorehabilitation Devices Market to Hit USD 2 Billion by 2025 | Medtronic, Bos …
The global neurorehabilitation devices market size is valued at US$ 1.48 billion in 2023 and is forecasted to surge to a size of US$ 5.4 billion by 2033-end. Worldwide neurorehabilitation system sales are projected to rise at an astronomical 13.8% CAGR over the next ten years.This impressive growth is fueled by the rising prevalence of neurological disorders, an aging global population, advancements in wearable and robotic technologies, and increasing demand…
Spectrometry Market to Hit USD 37.55 Billion by 2033 | Thermo Fisher Scientific, …
The global spectrometry market size accounts for a valuation of US$ 18.75 billion in 2023 and is forecasted to climb to US$ 37.55 billion by the end of 2033. As per this detailed Fact.MR research analysis, worldwide demand for spectrometry is predicted to rise at 7.1% CAGR over the next ten years.This robust growth is driven by increasing investments in research and development (R&D), advancements in spectrometry technologies, expanding applications…
Softgel Capsules Market to Reach USD 2.16 Billion by 2033 | Catalent, Aenova, Fu …
The global softgel capsules market size stands at US$ 1.17 billion in 2023. As per the recently published research report by Fact.MR, worldwide sales of softgel capsules are predicted to rise at a CAGR of 6.3% and reach US$ 2.16 billion by 2033-end. This growth is fueled by the increasing demand for softgel capsules in the pharmaceutical and healthcare sectors, driven by their versatile applications in treating cardiovascular, inflammatory, and…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
